Key Takeaways
- • Opentrons Labworks, a Brooklyn, NY-based company, raised $40 million in a Series E financing round, according to Massinvestor.
- • The round was led by healthcare investor Avego, with additional investment from BroadOak Capital Partners.
- • The company plans to use the proceeds to scale its robotics, software, and data infrastructure tools.
Summary
According to the company, the new capital will be deployed to scale its robotics, software, and data infrastructure tools. The source material does not disclose the post-money valuation, the full composition of investors, or specific revenue, customer, or product metrics, so those details cannot be confirmed from the available reporting.
The Series E close positions Opentrons to expand its lab automation platform, a segment that combines laboratory robotics with software and data systems. Institutional investors tracking life sciences tooling may view the round as a signal of continued capital availability for lab automation companies at a late-stage private financing.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.